Aaron Kantoff - 24 Oct 2023 Form 4 Insider Report for Tourmaline Bio, Inc. (TRML)

Role
Director
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
Issuer symbol
TRML
Transactions as of
24 Oct 2023
Net transactions value
+$88,950
Form type
4
Filing time
26 Oct 2023, 17:00:17 UTC
Previous filing
23 Oct 2023
Next filing
03 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TALS Common Stock Purchase $88,950 +7,500 +20% $11.86 45,391 24 Oct 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.